Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Device Week, 4 March 2022 – FDA Gets First Feedback On QMSR Draft Reg

Executive Summary

In this episode of Device Week: A US FDA meeting on 2 March generated the first public comments the agency has heard on its proposed Quality Management System Regulation, including some industry concerns around when device makers would have to transition to the new QMSR, if finalized.

Listen to the podcast via the player below:

The archive of Medtech Insight’s Device Week, Digital Health Roundups, Speaking of Medtech and the rest of Informa Pharma Intelligence’s podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud, Tune In, and Spotify Podcasts.

Medtech Insight articles addressing topics discussed in this episode:


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts